FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1483014275> ?p ?o ?g. }

• W1483014275 endingPage "444" @default.
• W1483014275 startingPage "437" @default.
• W1483014275 abstract "In clinical studies of glucagon-like peptide-1 (GLP-1) agonists used in the management of patients with type 2 diabetes, there is often a small accompanying fall in blood pressure. The mechanism underlying this effect is not known, although exenatide, a GLP-1 mimetic, has acute regional vasodilator properties in rats. We have therefore studied the haemodynamic effects of exenatide in healthy male volunteers.We compared the effects of a single 10 µg subcutaneous injection of exenatide with placebo in a double-blind, randomized, crossover study. For 2 h after dosing, haemodynamic measurements were made using a Finometer, venous occlusion plethysmography and Doppler ultrasound. The urine sodium : creatinine excretion ratio was determined.At the end of the study when exenatide was compared with placebo, heart rate had risen by a mean of 8.2 (95% CI 4.2, 12.2, P < 0.01) beats min(-1) , cardiac output by a mean of 1.2 (95% CI 0.42, 20.3, P < 0.05) l min(-1) and total peripheral resistance had fallen by 120 (95% CI -8, -233, P < 0.05) dyn s cm(-5) .There were no differences in blood pressure. The urinary sodium : creatinine ratio was increased by mean 12.4 (95% CI 4.6, 20.2, P < 0.05) mmol mmol(-1) when exenatide was compared with placebo.Exenatide has significant haemodynamic effects in healthy volunteers. The results of this study are consistent with exenatide having both vasodilator and natriuretic properties. The vascular changes may contribute to the hypotensive effect of exenatide when used chronically in patients with diabetes." @default.
• W1483014275 created "2016-06-24" @default.
• W1483014275 creator A5009102492 @default.
• W1483014275 creator A5016583531 @default.
• W1483014275 creator A5024203094 @default.
• W1483014275 creator A5037925341 @default.
• W1483014275 date "2012-08-06" @default.
• W1483014275 modified "2023-10-14" @default.
• W1483014275 title "Investigation of the haemodynamic effects of exenatide in healthy male subjects" @default.
• W1483014275 cites W1831731874 @default.
• W1483014275 cites W1964738340 @default.
• W1483014275 cites W1968315455 @default.
• W1483014275 cites W1977102586 @default.
• W1483014275 cites W1977179808 @default.
• W1483014275 cites W1983000201 @default.
• W1483014275 cites W2000976083 @default.
• W1483014275 cites W2005140805 @default.
• W1483014275 cites W2008191001 @default.
• W1483014275 cites W2011601530 @default.
• W1483014275 cites W2048929025 @default.
• W1483014275 cites W2068545996 @default.
• W1483014275 cites W2070710390 @default.
• W1483014275 cites W2078128383 @default.
• W1483014275 cites W2087263714 @default.
• W1483014275 cites W2093738306 @default.
• W1483014275 cites W2103525547 @default.
• W1483014275 cites W2106036385 @default.
• W1483014275 cites W2111765225 @default.
• W1483014275 cites W2113094401 @default.
• W1483014275 cites W2116961842 @default.
• W1483014275 cites W2129377335 @default.
• W1483014275 cites W2129730863 @default.
• W1483014275 cites W2137352234 @default.
• W1483014275 cites W2142097676 @default.
• W1483014275 cites W2142400535 @default.
• W1483014275 cites W2143872077 @default.
• W1483014275 cites W2154595662 @default.
• W1483014275 cites W2160001758 @default.
• W1483014275 cites W2169562373 @default.
• W1483014275 cites W2169976140 @default.
• W1483014275 cites W2170606300 @default.
• W1483014275 cites W2546871279 @default.
• W1483014275 doi "https://doi.org/10.1111/j.1365-2125.2012.04214.x" @default.
• W1483014275 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3477345" @default.
• W1483014275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22320349" @default.
• W1483014275 hasPublicationYear "2012" @default.
• W1483014275 type Work @default.
• W1483014275 sameAs 1483014275 @default.
• W1483014275 citedByCount "46" @default.
• W1483014275 countsByYear W14830142752012 @default.
• W1483014275 countsByYear W14830142752013 @default.
• W1483014275 countsByYear W14830142752014 @default.
• W1483014275 countsByYear W14830142752015 @default.
• W1483014275 countsByYear W14830142752016 @default.
• W1483014275 countsByYear W14830142752017 @default.
• W1483014275 countsByYear W14830142752018 @default.
• W1483014275 countsByYear W14830142752019 @default.
• W1483014275 countsByYear W14830142752021 @default.
• W1483014275 countsByYear W14830142752022 @default.
• W1483014275 countsByYear W14830142752023 @default.
• W1483014275 crossrefType "journal-article" @default.
• W1483014275 hasAuthorship W1483014275A5009102492 @default.
• W1483014275 hasAuthorship W1483014275A5016583531 @default.
• W1483014275 hasAuthorship W1483014275A5024203094 @default.
• W1483014275 hasAuthorship W1483014275A5037925341 @default.
• W1483014275 hasBestOaLocation W14830142752 @default.
• W1483014275 hasConcept C126322002 @default.
• W1483014275 hasConcept C134018914 @default.
• W1483014275 hasConcept C142724271 @default.
• W1483014275 hasConcept C164705383 @default.
• W1483014275 hasConcept C178853913 @default.
• W1483014275 hasConcept C204787440 @default.
• W1483014275 hasConcept C27081682 @default.
• W1483014275 hasConcept C2776452961 @default.
• W1483014275 hasConcept C2777180221 @default.
• W1483014275 hasConcept C2777953023 @default.
• W1483014275 hasConcept C2780533449 @default.
• W1483014275 hasConcept C555293320 @default.
• W1483014275 hasConcept C58245268 @default.
• W1483014275 hasConcept C71924100 @default.
• W1483014275 hasConcept C84393581 @default.
• W1483014275 hasConcept C87813604 @default.
• W1483014275 hasConceptScore W1483014275C126322002 @default.
• W1483014275 hasConceptScore W1483014275C134018914 @default.
• W1483014275 hasConceptScore W1483014275C142724271 @default.
• W1483014275 hasConceptScore W1483014275C164705383 @default.
• W1483014275 hasConceptScore W1483014275C178853913 @default.
• W1483014275 hasConceptScore W1483014275C204787440 @default.
• W1483014275 hasConceptScore W1483014275C27081682 @default.
• W1483014275 hasConceptScore W1483014275C2776452961 @default.
• W1483014275 hasConceptScore W1483014275C2777180221 @default.
• W1483014275 hasConceptScore W1483014275C2777953023 @default.
• W1483014275 hasConceptScore W1483014275C2780533449 @default.
• W1483014275 hasConceptScore W1483014275C555293320 @default.
• W1483014275 hasConceptScore W1483014275C58245268 @default.
• W1483014275 hasConceptScore W1483014275C71924100 @default.
• W1483014275 hasConceptScore W1483014275C84393581 @default.
• W1483014275 hasConceptScore W1483014275C87813604 @default.

• next